National Bank of Canada’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.15K Sell
558
-10
-2% -$41 ﹤0.01% 2606
2025
Q4
$2.37K Buy
568
+84
+17% +$325 ﹤0.01% 2546
2025
Q3
$1.59K Sell
484
-166
-26% -$469 ﹤0.01% 2610
2025
Q2
$916 Buy
+650
New +$924 ﹤0.01% 2714

Other funds holding PGEN

National Bank of Canada's PGEN Position: Q1 2026 in Review

National Bank of Canada reduced its Precigen (PGEN) stake by 1.8% in Q1 2026, selling an estimated $41 and leaving 558 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2606.

National Bank of Canada first reported a position in PGEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.37K in Q4 2025. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • National Bank of Canada held 558 shares of Precigen worth $2.15K as of Q1 2026.
  • National Bank of Canada sold 10 Precigen shares in Q1 2026, an estimated $41.
  • Precigen made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2606 holding.
  • National Bank of Canada first reported a position in Precigen in Q2 2025 and has held it in 4 quarters since.
  • National Bank of Canada's Precigen position peaked at $2.37K in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.